Thrivent Financial for Lutherans’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Buy |
37,636
+1,701
| +5% | +$111K | 0.01% | 1217 |
|
|
2025
Q1 | $2.54M | Buy |
35,935
+2,019
| +6% | +$142K | 0.01% | 1129 |
|
|
2024
Q4 | $2.23M | Buy |
33,916
+1,407
| +4% | +$92.5K | ﹤0.01% | 1350 |
|
|
2024
Q3 | $2.3M | Buy |
32,509
+6,214
| +24% | +$439K | ﹤0.01% | 1349 |
|
|
2024
Q2 | $1.74M | Buy |
26,295
+2,272
| +9% | +$151K | ﹤0.01% | 1472 |
|
|
2024
Q1 | $1.63M | Buy |
24,023
+2,672
| +13% | +$181K | ﹤0.01% | 1567 |
|
|
2023
Q4 | $1.32M | Buy |
21,351
+5,556
| +35% | +$343K | ﹤0.01% | 1666 |
|
|
2023
Q3 | $932K | Buy |
15,795
+3,510
| +29% | +$207K | ﹤0.01% | 1788 |
|
|
2023
Q2 | $733K | Buy |
12,285
+936
| +8% | +$55.8K | ﹤0.01% | 1997 |
|
|
2023
Q1 | $663K | Buy |
11,349
+1,425
| +14% | +$83.2K | ﹤0.01% | 2008 |
|
|
2022
Q4 | $616K | Buy |
9,924
+603
| +6% | +$37.4K | ﹤0.01% | 2019 |
|
|
2022
Q3 | $527K | Buy |
9,321
+378
| +4% | +$21.4K | ﹤0.01% | 2052 |
|
|
2022
Q2 | $571K | Sell |
8,943
-1,857
| -17% | -$119K | ﹤0.01% | 2028 |
|
|
2022
Q1 | $699K | Buy |
+10,800
| New | +$699K | ﹤0.01% | 2030 |
|